Article
Glycolysis inhibition by 2-deoxy-D-glucose reverts the metastatic phenotype in vitro and in vivo.
Clinical & experimental metastasis - 1 Dec 2011
Sottnik Joseph L, Lori Janet C, Rose Barbara J, Thamm Douglas H
Abstract excerpt
Metastasis is the primary cause of death from many tumors, and novel anti-metastatic therapies are necessary. Recently, we showed that metastatic tumors down-regulate key oxidative phosphorylation (OXPHOS) genes in favor of glycolysis, a further enhancement of the Warburg effect. Therefore, we sought to determine if restriction of glycolysis using 2-deoxy-D-glucose (2DG) would lead to increased utilization of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
